Genelux Price To Sales from 2010 to 2025

GNLX Stock   3.95  0.02  0.51%   
Genelux Common Price To Sales Ratio yearly trend continues to be fairly stable with very little volatility. Price To Sales Ratio is likely to outpace its year average in 2025.
Check Genelux Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genelux Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 883.5 K, Interest Expense of 4.8 M or Other Operating Expenses of 16.8 M, as well as many indicators such as Price To Sales Ratio of 1.9 K, Dividend Yield of 0.0 or PTB Ratio of 16.61. Genelux financial statements analysis is a perfect complement when working with Genelux Common Valuation or Volatility modules.
  
Check out the analysis of Genelux Common Correlation against competitors.
For more information on how to buy Genelux Stock please use our How to Invest in Genelux Common guide.

Latest Genelux Common's Price To Sales Growth Pattern

Below is the plot of the Price To Sales Ratio of Genelux Common over the last few years. Price to Sales Ratio is figured by comparing Genelux Common stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Genelux Common sales, a figure that is much harder to manipulate than other Genelux Common multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Genelux Common's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genelux Common's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 16,967 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Genelux Price To Sales Regression Statistics

Arithmetic Mean369.07
Geometric Mean34.45
Coefficient Of Variation207.29
Mean Deviation577.56
Median13.64
Standard Deviation765.03
Sample Variance585,265
Range2K
R-Value0.67
Mean Square Error341,739
R-Squared0.46
Significance0
Slope108.39
Total Sum of Squares8.8M

Genelux Price To Sales History

2025 1902.53
2024 1811.93
2023 2013.26

About Genelux Common Financial Statements

Genelux Common investors use historical fundamental indicators, such as Genelux Common's Price To Sales, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Genelux Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Sales Ratio1.8 K1.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Genelux Stock Analysis

When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.